Top Markets
Coin of the day
Promore Pharma AB (publ) Promore Pharma AB (publ)

Promore Pharma AB (publ)

PROMO
Rankning i aktier #25506
Promore Pharma AB (publ) is a Swedish biopharmaceutical firm dedicated to... Promore Pharma AB (publ) is a Swedish biopharmaceutical firm dedicated to advancing peptide-based drug therapies. The company's development pipeline features PXL01, currently undergoing Phase IIa studies for its potential in preventing post-surgical adhesions and scars, mitigating dermal scarring, and aiding hand tendon repair. Another key asset, LL-37, is engaged in Phase IIb clinical trials to address venous leg ulcers, stimulate the healing of persistent wounds, and treat diabetic foot ulcers. Additionally, Promore Pharma has partnered with Fidia Farmaceutici S.p.A. for the production of hyaluronic acid syringes. Founded in 2002, the company, formerly known as Lipopeptide AB until its rebranding in January 2017, maintains its headquarters in Solna, Sweden.
Aktiekurs
$1.34
Senast synkroniserad: 2024-02-14
Marknadsvärde
$48.96M
Förändring (1 dag)
-12.94%
Förändring (1 år)
0.00%
Land
SE
Handel Promore Pharma AB (publ) (PROMO)

Kategori

Historik för aktiesplit för Promore Pharma AB (publ) (PROMO)
Aktien Promore Pharma AB (publ) (symbol: PROMO) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 21, 2026.
En PROMO-aktie köpt före Aug 21, 2026 motsvarar nu 0 PROMO-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
US